Table 1. Properties of NFAT inhibitors.
Code | ChemB* | Nc3† | ID-Phos‡ | GCR§ | CN¶ | IC50∥ |
---|---|---|---|---|---|---|
1 | 114006 | C | Phos. | C/N | Neg. | <25 |
2 | 115555 | C | Phos | N | Neg. | 10 |
3 | 115805 | C | Phos | N | Neg. | <40 |
4 | 143072 | C | Phos | N | Neg. | <25 |
5 | 149521 | C | Phos | N | Neg. | <40 |
6 | 190027 | C | De-Phos | N | Neg. | <10 |
7 | 202034 | C | Phos | N | Neg. | 14 |
8 | 205327 | C | De-phos | N | Neg. | 40 |
9 | 211950 | C | Phos | N | Neg. | <20 |
10 | 219735 | C | Phos | N | Neg. | 15 |
11 | 228195 | C | De-phos | N | Neg. | 22 |
12 | 232755 | C | De-phos | N | Neg. | 32 |
13 | 156381 | C | Phos | N | Neg. | 15 |
14 | 103885 | C | Phos | N | Neg. | <10 |
Chembridge Corporation code for compounds.
Effect on NFATc3 localization in the presence of calcium ionophore (C, cytoplasmic, N, nuclear).
Effect on NFATc3 phosphorylation status in the presence of ionomycin.
Effect on the dexamethasone-induced translocation of the glucocorticoid receptor to the nucleus (C, cytoplasmic; N, nuclear).
Effect on calcineurin in vivo. Neg., negative.
Apparent concentration of inhibitor at which 50% of NFATc3 fails to enter the nucleus.